1. Absolute Bioavailability of Vemurafenib in Patients With BRAFV600 Mutation–Positive Malignancies. Issue 4 (21st February 2020) Authors: Zhang, Weijiang; Colburn, Dawn; Simmons, Brian; Papai, Zsuzsanna; Bertran, Enric; Schadt, Simone; Husser, Christophe; Forbes, Harper; Roethlisberger, Dieter; Hartung, Thomas Journal: Clinical pharmacology in drug development Issue: Volume 9:Issue 4(2020) Page Start: 496 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Body weight-supported treadmill training vs. overground walking training for persons with chronic stroke: a pilot randomized controlled trial. (September 2014) Authors: Combs-Miller, Stephanie A; Kalpathi Parameswaran, Anu; Colburn, Dawn; Ertel, Tara; Harmeyer, Amanda; Tucker, Lindsay; Schmid, Arlene A Journal: Clinical rehabilitation Issue: Volume 28:Number 9(2014) Page Start: 873 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effect of Vemurafenib on the Pharmacokinetics of a Single Dose of Digoxin in Patients With BRAFV600 Mutation–Positive Metastatic Malignancy. (12th April 2018) Authors: Zhang, Weijiang; McIntyre, Christine; Kuhn, Melissa; Forbes, Harper; Kim, Tae Min; Lee, Jeeyun; Demidov, Lev; Colburn, Dawn Journal: Journal of clinical pharmacology Issue: Volume 58:Number 8(2018) Page Start: 1067 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Safety and efficacy of vismodegib in relapsed/refractory acute myeloid leukaemia: results of a phase Ib trial. (11th September 2018) Authors: Bixby, Dale; Noppeney, Richard; Lin, Tara L.; Cortes, Jorge; Krauter, Jürgen; Yee, Karen; Medeiros, Bruno C.; Krämer, Alwin; Assouline, Sarit; Fiedler, Walter; Dimier, Natalie; Simmons, Brian P.; Riehl, Todd; Colburn, Dawn Journal: British journal of haematology Issue: Volume 185:Number 3(2019) Page Start: 595 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗